ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Valeant Pharmaceuticals Completes Sale of CeraVe, AcneFree and AMBI Skincare Brands to L'Oréal
March 07, 2017Valeant Pharmaceuticals has completed the previously announced sale of its CeraVe, AcneFree and AMBI skincare brands to L'Oréal for $1.3 billion in cash. Valeant will use net proceeds from the sale to permanently repay term loan debt under its Senior Cred -
Valeant to Sell CeraVe, AcneFree and AMBI Skincare Brands to L'Oreal for $1.3B
January 11, 2017Valeant Pharmaceuticals has entered into an agreement to sell its CeraVe, AcneFree and AMBI skincare brands to L'Oréal for $1.3 billion in cash. The CeraVe, AcneFree, and AMBI product lines have annualized revenue of approximately of $168M.
Pharma Sources Insight January 2025
